Podocyte mRNA in the urinary sediment of minimal change nephropathy and focal segmental glomerulosclerosis
Related Experiment Video
Updated: Apr 5, 2026

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
Published on: July 8, 2020
Background:
Podocyte depletion is a characteristic feature of progressive renal failure. We hypothesize that studying the podocyte mRNA level in urinary sediment may provide diagnostic and prognostic information in adult nephrotic syndrome.
Methods:
We studied 25 patients with minimal change nephropathy (MCN), 25 with focal segmental glomerulosclerosis (FSGS), and 17 healthy controls. The mRNA levels of nephrin, podocin, and synaptopodin in urinary sediment were quantified.
Results:
There were significant differences in the urinary sediment nephrin and podocin, but not synaptopodin, mRNA levels between diagnosis groups. Post-hoc analysis further showed that urinary nephrin mRNA levels of the MCN group were lower than those in the control and FSGS groups, although the difference between MCN and FSGS groups did not reach statistical significance. The degree of proteinuria inversely correlated with urinary nephrin mRNA levels in the MCN (r = -0.526, p = 0.007) as well as in the FSGS group (r = -0.521, p = 0.008). For the FSGS group, the rate of renal function decline significantly correlated with baseline urinary synaptopodin mRNA levels (r = -0.496, p = 0.012).
Conclusions:
Urinary nephrin and podocin mRNA levels were reduced in patients with MCN and probably FSGS, and the magnitude of reduction correlated with the degree of proteinuria. Urinary synaptopodin mRNA levels correlated with the subsequent rate of renal function decline in patients with FSGS. Our result indicates that urine sediment podocyte mRNA levels provide novel insights in the pathophysiology of nephrotic syndrome and could be useful for risk stratification.
Insights
Urinary podocyte mRNA levels, including nephrin and podocin, are reduced in nephrotic syndrome and correlate with proteinuria. Synaptopodin mRNA levels in urine predict kidney function decline in focal segmental glomerulosclerosis (FSGS).
Area of Science:
- Nephrology
- Molecular Biology
- Biomarker Discovery
Background:
- Podocyte depletion is a hallmark of progressive renal failure.
- Urinary podocyte mRNA analysis may offer diagnostic and prognostic value in nephrotic syndrome.
Purpose of the Study:
- To investigate the utility of urinary sediment podocyte mRNA levels for diagnosing and predicting outcomes in adult nephrotic syndrome.
- To quantify nephrin, podocin, and synaptopodin mRNA in patients with minimal change nephropathy (MCN) and focal segmental glomerulosclerosis (FSGS).
Main Methods:
- Quantified mRNA levels of nephrin, podocin, and synaptopodin in urinary sediment from 25 MCN patients, 25 FSGS patients, and 17 healthy controls.
- Analyzed correlations between mRNA levels, proteinuria, and renal function decline.
Main Results:
- Urinary nephrin and podocin mRNA levels differed significantly between diagnostic groups, with lower levels in MCN compared to controls and FSGS.
- Proteinuria inversely correlated with urinary nephrin mRNA in both MCN and FSGS groups.
- Urinary synaptopodin mRNA levels correlated with the rate of renal function decline in FSGS patients.
Conclusions:
- Reduced urinary nephrin and podocin mRNA levels are associated with nephrotic syndrome and correlate with proteinuria severity.
- Urinary synaptopodin mRNA levels serve as a potential biomarker for predicting renal function decline in FSGS.
- Urinary sediment podocyte mRNA analysis provides novel insights into nephrotic syndrome pathophysiology and aids in risk stratification.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Urine Studies I: Urinalysis
Nephrotic Syndrome II : Assessment and Medical Management
Nephrons

